 | • レポートコード：MRC2-11QY04518 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はリウマチ治療のグローバル市場について調査・分析したレポートです。種類別（関節リウマチ、変形性関節症、狼瘡、痛風、強直性脊椎炎、その他）市場規模、用途別（小売薬局、オンライン薬局、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別リウマチ治療の競争状況、市場シェア ・世界のリウマチ治療市場：種類別市場規模 2015年-2020年（関節リウマチ、変形性関節症、狼瘡、痛風、強直性脊椎炎、その他） ・世界のリウマチ治療市場：種類別市場規模予測 2021年-2026年（関節リウマチ、変形性関節症、狼瘡、痛風、強直性脊椎炎、その他） ・世界のリウマチ治療市場：用途別市場規模 2015年-2020年（小売薬局、オンライン薬局、病院） ・世界のリウマチ治療市場：用途別市場規模予測 2021年-2026年（小売薬局、オンライン薬局、病院） ・北米のリウマチ治療市場分析：米国、カナダ ・ヨーロッパのリウマチ治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのリウマチ治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のリウマチ治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのリウマチ治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Pfizer、Bristol-Myers Squibb Company、Merck、Amgen、Janssen Biotech、Novartis AG、Genentech、Takeda Pharmaceutical、Sanofi ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.
The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025.
Market Analysis and Insights: Global Rheumatology therapeutics Market
The global Rheumatology therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rheumatology therapeutics Scope and Market Size
Rheumatology therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatology therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck
Amgen
Janssen Biotech
Novartis AG
Genentech
Takeda Pharmaceutical
Sanofi
Market segment by Type, the product can be split into
Rheumatoid Arthritis
Osteoarthritis
Lupus
Gout
Ankylosing Spondylitis
Other
Market segment by Application, split into
Retail Pharmacy
Online Pharmacy
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rheumatology therapeutics Revenue
1.4 Market by Type
1.4.1 Global Rheumatology therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rheumatoid Arthritis
1.4.3 Osteoarthritis
1.4.4 Lupus
1.4.5 Gout
1.4.6 Ankylosing Spondylitis
1.4.7 Other
1.5 Market by Application
1.5.1 Global Rheumatology therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacy
1.5.3 Online Pharmacy
1.5.4 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Rheumatology therapeutics Market Perspective (2015-2026)
2.2 Global Rheumatology therapeutics Growth Trends by Regions
2.2.1 Rheumatology therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rheumatology therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Rheumatology therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rheumatology therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Rheumatology therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Rheumatology therapeutics Players by Market Size
3.1.1 Global Top Rheumatology therapeutics Players by Revenue (2015-2020)
3.1.2 Global Rheumatology therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Rheumatology therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rheumatology therapeutics Market Concentration Ratio
3.2.1 Global Rheumatology therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rheumatology therapeutics Revenue in 2019
3.3 Rheumatology therapeutics Key Players Head office and Area Served
3.4 Key Players Rheumatology therapeutics Product Solution and Service
3.5 Date of Enter into Rheumatology therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rheumatology therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Rheumatology therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Rheumatology therapeutics Market Size by Application (2015-2020)
5.2 Global Rheumatology therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rheumatology therapeutics Market Size (2015-2020)
6.2 Rheumatology therapeutics Key Players in North America (2019-2020)
6.3 North America Rheumatology therapeutics Market Size by Type (2015-2020)
6.4 North America Rheumatology therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Rheumatology therapeutics Market Size (2015-2020)
7.2 Rheumatology therapeutics Key Players in Europe (2019-2020)
7.3 Europe Rheumatology therapeutics Market Size by Type (2015-2020)
7.4 Europe Rheumatology therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Rheumatology therapeutics Market Size (2015-2020)
8.2 Rheumatology therapeutics Key Players in China (2019-2020)
8.3 China Rheumatology therapeutics Market Size by Type (2015-2020)
8.4 China Rheumatology therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Rheumatology therapeutics Market Size (2015-2020)
9.2 Rheumatology therapeutics Key Players in Japan (2019-2020)
9.3 Japan Rheumatology therapeutics Market Size by Type (2015-2020)
9.4 Japan Rheumatology therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Rheumatology therapeutics Market Size (2015-2020)
10.2 Rheumatology therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rheumatology therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Rheumatology therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Rheumatology therapeutics Market Size (2015-2020)
11.2 Rheumatology therapeutics Key Players in India (2019-2020)
11.3 India Rheumatology therapeutics Market Size by Type (2015-2020)
11.4 India Rheumatology therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Rheumatology therapeutics Market Size (2015-2020)
12.2 Rheumatology therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Rheumatology therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Rheumatology therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Rheumatology therapeutics Introduction
13.1.4 AbbVie Revenue in Rheumatology therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Rheumatology therapeutics Introduction
13.2.4 Pfizer Revenue in Rheumatology therapeutics Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bristol-Myers Squibb Company
13.3.1 Bristol-Myers Squibb Company Company Details
13.3.2 Bristol-Myers Squibb Company Business Overview
13.3.3 Bristol-Myers Squibb Company Rheumatology therapeutics Introduction
13.3.4 Bristol-Myers Squibb Company Revenue in Rheumatology therapeutics Business (2015-2020)
13.3.5 Bristol-Myers Squibb Company Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Rheumatology therapeutics Introduction
13.4.4 Merck Revenue in Rheumatology therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Amgen
13.5.1 Amgen Company Details
13.5.2 Amgen Business Overview
13.5.3 Amgen Rheumatology therapeutics Introduction
13.5.4 Amgen Revenue in Rheumatology therapeutics Business (2015-2020)
13.5.5 Amgen Recent Development
13.6 Janssen Biotech
13.6.1 Janssen Biotech Company Details
13.6.2 Janssen Biotech Business Overview
13.6.3 Janssen Biotech Rheumatology therapeutics Introduction
13.6.4 Janssen Biotech Revenue in Rheumatology therapeutics Business (2015-2020)
13.6.5 Janssen Biotech Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview
13.7.3 Novartis AG Rheumatology therapeutics Introduction
13.7.4 Novartis AG Revenue in Rheumatology therapeutics Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Genentech
13.8.1 Genentech Company Details
13.8.2 Genentech Business Overview
13.8.3 Genentech Rheumatology therapeutics Introduction
13.8.4 Genentech Revenue in Rheumatology therapeutics Business (2015-2020)
13.8.5 Genentech Recent Development
13.9 Takeda Pharmaceutical
13.9.1 Takeda Pharmaceutical Company Details
13.9.2 Takeda Pharmaceutical Business Overview
13.9.3 Takeda Pharmaceutical Rheumatology therapeutics Introduction
13.9.4 Takeda Pharmaceutical Revenue in Rheumatology therapeutics Business (2015-2020)
13.9.5 Takeda Pharmaceutical Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview
13.10.3 Sanofi Rheumatology therapeutics Introduction
13.10.4 Sanofi Revenue in Rheumatology therapeutics Business (2015-2020)
13.10.5 Sanofi Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Rheumatology therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Rheumatology therapeutics Revenue
Table 3. Ranking of Global Top Rheumatology therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rheumatology therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rheumatoid Arthritis
Table 6. Key Players of Osteoarthritis
Table 7. Key Players of Lupus
Table 8. Key Players of Gout
Table 9. Key Players of Ankylosing Spondylitis
Table 10. Key Players of Other
Table 11. Global Rheumatology therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Rheumatology therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Rheumatology therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Rheumatology therapeutics Market Share by Regions (2015-2020)
Table 15. Global Rheumatology therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Rheumatology therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Rheumatology therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Rheumatology therapeutics Players
Table 22. Global Rheumatology therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Rheumatology therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Rheumatology therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology therapeutics as of 2019)
Table 25. Global Rheumatology therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Rheumatology therapeutics Product Solution and Service
Table 28. Date of Enter into Rheumatology therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Rheumatology therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Rheumatology therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Rheumatology therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Rheumatology therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 38. North America Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Rheumatology therapeutics Market Share by Type (2015-2020)
Table 40. North America Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Rheumatology therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 44. Europe Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Rheumatology therapeutics Market Share by Type (2015-2020)
Table 46. Europe Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Rheumatology therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 50. China Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Rheumatology therapeutics Market Share by Type (2015-2020)
Table 52. China Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Rheumatology therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 56. Japan Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Rheumatology therapeutics Market Share by Type (2015-2020)
Table 58. Japan Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Rheumatology therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Rheumatology therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Rheumatology therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 68. India Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Rheumatology therapeutics Market Share by Type (2015-2020)
Table 70. India Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Rheumatology therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Rheumatology therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Rheumatology therapeutics Market Share (2019-2020)
Table 74. Central & South America Rheumatology therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Rheumatology therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Rheumatology therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Rheumatology therapeutics Market Share by Application (2015-2020)
Table 78. AbbVie Company Details
Table 79. AbbVie Business Overview
Table 80. AbbVie Product
Table 81. AbbVie Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 82. AbbVie Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Product
Table 86. Pfizer Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 87. Pfizer Recent Development
Table 88. Bristol-Myers Squibb Company Company Details
Table 89. Bristol-Myers Squibb Company Business Overview
Table 90. Bristol-Myers Squibb Company Product
Table 91. Bristol-Myers Squibb Company Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 92. Bristol-Myers Squibb Company Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Product
Table 96. Merck Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 97. Merck Recent Development
Table 98. Amgen Company Details
Table 99. Amgen Business Overview
Table 100. Amgen Product
Table 101. Amgen Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 102. Amgen Recent Development
Table 103. Janssen Biotech Company Details
Table 104. Janssen Biotech Business Overview
Table 105. Janssen Biotech Product
Table 106. Janssen Biotech Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 107. Janssen Biotech Recent Development
Table 108. Novartis AG Company Details
Table 109. Novartis AG Business Overview
Table 110. Novartis AG Product
Table 111. Novartis AG Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 112. Novartis AG Recent Development
Table 113. Genentech Business Overview
Table 114. Genentech Product
Table 115. Genentech Company Details
Table 116. Genentech Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 117. Genentech Recent Development
Table 118. Takeda Pharmaceutical Company Details
Table 119. Takeda Pharmaceutical Business Overview
Table 120. Takeda Pharmaceutical Product
Table 121. Takeda Pharmaceutical Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 122. Takeda Pharmaceutical Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Business Overview
Table 125. Sanofi Product
Table 126. Sanofi Revenue in Rheumatology therapeutics Business (2015-2020) (Million US$)
Table 127. Sanofi Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatology therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Rheumatoid Arthritis Features
Figure 3. Osteoarthritis Features
Figure 4. Lupus Features
Figure 5. Gout Features
Figure 6. Ankylosing Spondylitis Features
Figure 7. Other Features
Figure 8. Global Rheumatology therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Retail Pharmacy Case Studies
Figure 10. Online Pharmacy Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Rheumatology therapeutics Report Years Considered
Figure 13. Global Rheumatology therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Rheumatology therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Rheumatology therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Rheumatology therapeutics Market Share by Players in 2019
Figure 18. Global Top Rheumatology therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatology therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Rheumatology therapeutics Revenue in 2019
Figure 20. North America Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Rheumatology therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
痛風治療薬の世界市場（～2026年） Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to …- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 強直性脊椎炎治療の世界市場（～2026年） Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and p…
- 乾癬性関節炎治療薬の世界市場（～2026年） Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis. Market…
- 強直性脊椎炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ankylosing Spondylitis Drug Market The global Ankylosing Spondylitis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ankylosing Spondylitis Drug Scope and Market Size Ankylosin…